Viral infection and allergy: Lower airway

Allergy and Asthma Proceedings

Volumn 23, Issue 4, 2002, Pages 229-232

  Skoner, David P ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ASTHMA; BLOOD; CHILD; CHILD WELFARE; HUMAN; INFANT; INFANT WELFARE; NEWBORN; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; REVIEW; VIROLOGY; VIRUS INFECTION;

ASTHMA; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; HUMANS; IMMUNOGLOBULIN E; INFANT; INFANT WELFARE; INFANT, NEWBORN; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 0036634359     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Duff AL, Pomeranz ES, Gelber LE, et al. Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics 92:535-540, 1993.
2. Pattemore PK, Johnston SL, and Bardin PG. Viruses as precipitants of asthma symptoms; 1. Epidemiology. Clin Exp Allergy 22:325-336, 1992.
3. Martinez FD, Morgan WJ, Wright AL, et al Diminished lung finction as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 319:1112-1117, 1988.
4. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BJM 310:1225-1229, 1995.
5. Minor TE, Dick EC, DeMeo AN, et al. Viruses as precipitants of asthmatic attacks in children. JAMA 227:292-298, 1974.
6. Nicholson KG, Rent J, and Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 307:982-986, 1993.
7. Bardin PG, Johnston SL, and Pattemore PK. Viruses as precipitants of asthma symptoms: II. Phyhsiology and mechanisms Clin Exp Allergy 22:802-822, 1992.
8. Skoner DP, Gentile DA, Fireman P, et al. Urinary histamine metabolite elevations during experimental influenza A infection. Ann Allergy Asthma Immunol 87.303-306, 2002.
9. Gentile D, Doyle W, Fireman P, and Skoner DP. Effect of experimental influenza A infection on systemic immune and inflammatory parameters in allergic and nonallergic adult subjects. Ann Allergy Asthma Immunol 87:496-500, 2001.
10. Skoner DP, Doyle WJ, Tanner EP, et al. Effect of rhinovirus 39 (RV-39) infection on immune and inflammatory parameters in allergic and non-allergic subjects. Clin Exp Allergy 25:561-567, 1995.
11. Bush RK, Busse W, Flaherty D, et aJ. Effects of experimental rhinovirus 16 infection on airways and leukocyte function in normal subjects. J Allergy Clin Immunol 61:80-87, 1978.
12. Igarashi Y, Skoner DP, Doyle WJ, et al. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections (URI). J Allergy Clin Immunol 92:722-731, 1993.
13. Noah TL, Henderson FW, Wortmen IA, et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 171:584-572, 1995.
14. Hayden FG, et al. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101:643-649, 1998.
15. Hakonarson H, Maskeri N, Carter C, and Grunstein MM. Regulation of TH1- and TH2-type cytokines expression and action in atopic asthmatic sensitized airways smooth muscle. J Clin Invest 103:1077-1087, 1999.
16. Grunstein MM, Hakonarson H, Maskeri N, et al. Intrinsic ICAM-1/ LFA-1 activation mediates altered responsiveness of atopic asthmatic airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 278: L1154-L1163, 2000.
17. Piedimonte G, et al. RSV upregulates expression of the substance P receptor in rat lungs. Am J Physiol 277:L831-L840, 1999.
18. King KA, et al. Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats. Am J Respir Cell Mol Biol 24:101-107, 2001.
19. Gern JE, Galagan DM, Jarjour NN, et al. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 155:1159-1161, 1997.
20. Fraenkel DJ, Bardin PG, Sanderson G, et al. Lower airway inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 151:879-886, 1995
21. Gentile DG, and Skoner D. Limitations of human experimental provocation models for investigating the virus-asthma link. In Asthma and Respiratory Infections. Skoner D, and Lenfant C (Eds). Chap. 9. New York: Marcel Dekker. Inc., 183-192, 2001.
22. Lemanske RF, Dick EC, Swenson CA, et al. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 83:1-10, 1989.
23. Calhoun WJ, Swenson CA, Dick EC, et al. Experimental rhinovirus 16 infection potentiates histamine release after antigen broncho-provocation in allergic subjects Am Rev Respir Dis 144:1267-1273, 1991.
24. Calhoun WJ, Dick EC, Schwartz LB, and Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 94:2200-2208, 1994.
25. Skoner DP, Doyle WJ, Serosky J, and Fireman P. Lower airway responses to influenza A virus in healthy allergic and non-allergic subjects. Am J Resp Crit Care Med 154:661-664, 1996.
26. Skoner DP, Doyle WJ, Seroky J, et al. Lower airway responses to rhinovirus 39 in healthy allergic and non-allergic subjects. Eur Respir J 9:1402-1409, 1996.
27. Angelini BA, Van Deusen MA, Doyle WJ, et al. Lower airway responses to rhinovirus-Hanks in healthy subjects with and without allergy. J Allergy Clin Immunol 99:618-619, 1997.
28. Proud D, Gwaltney JMJ, Hendley JO, et al. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis 169:1007-1011, 1994.
29. Gern JE, Dick EC, Lee WM, et al. Rhinovirus enters but does not replicate inside monocytes and airway macrophages, J Immunol 156:621-627, 1996.
30. Subauste MC, Jacoby DB, Richards SM, and Proud D. Infection of a human respiratory epithelial cell line with rhinovirus - induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 96:549-557, 1995.
31. Yuta A, Doyle WJ, Gaumond E, et al. Rhinovirus infection induces mucous hypersecretion. AM J Physiol 274:L1017-L1023, 1998.
32. Gentile DA, Doyle W, Whiteside T, et al. Increased interleukin-6 levels in nasal lavages following experimental influenza A viral infection. Clin Diagn Lab Immunol 5:604-608, 1998.
33. Skoner DP, Gentile DA, Patel A, and Doyle JW. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus J Infect Dis 180:10-14, 1999.
34. Einarsson O, Geba GP, Zhu Z, et al. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. Clin Invest 97:915-924, 1996.
35. Fleming HE, Little FF, Schnurr D, et al. Rhinovirus-16 colds in healthy and in asthmatic subjects - similar changes in upper and lower airways. Am J Respir Crit Care Med 160:100-108, 1999
36. Grunberg K, et al. Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med 160:1375-1380, 1999.
37. Jarjour NN, Gern JE, et al. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol 105:1169-1177, 2000.
38. Cheung D, Dick EC, Timmers MC, et al. Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Cnt Care Med 152:1490-1496, 1995
39. Grunberg K, Kuijpers EA, de Klerk EP, et al. Effects of experimental rhinovirus 16 infection on airway hyperresponsiveness to bradykinin in asthmatic subjects in vivo. Am J Respir Crit Care Med 155:833-838, 1997.